| Phase 3 |
| NCT06296706 |
A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric… |
Gastric Cancer |
Recruiting |
2024-11-14 |
| NCT06313086 |
DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast… |
HER2-positive Breast Cancer |
Recruiting |
2024-05-10 |
| NCT07805135 |
A Study of HB1801 Versus Docetaxel (Taxotere®) in Patients With Advanced Breast Cancer |
HER2-Negative Advanced Breast Cancer |
Not Yet Recruiting |
2026-09-04 |
| NCT07623824 |
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting… |
Diagnosed With Acromegaly, Currently in the Active Stage of the Disease |
Not Yet Recruiting |
2026-06-03 |
| NCT07163364 |
A Study to Evaluate the Effects and Safety of Hydroxocobalamin in Participants With… |
Methylmalonic Acidemia (MMA) |
Not Yet Recruiting |
2025-09-09 |
| NCT04668690 |
Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients… |
Peripheral T Cell Lymphoma |
Active, Not Recruiting |
2025-05-31 |
| NCT06929325 |
Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2… |
HR+/HER2- Advanced/Metastatic Breast Cancer |
Not Yet Recruiting |
2025-04-16 |
| NCT06827431 |
The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With… |
Major Depressive Disorder (MDD) |
Not Yet Recruiting |
2025-02-14 |
| NCT06771245 |
A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine… |
Mild-to-moderate Essential Hypertension |
Not Yet Recruiting |
2025-01-13 |
| NCT06492941 |
A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic… |
Advanced Pancreatic Cancer |
Not Yet Recruiting |
2024-07-09 |
| NCT05901935 |
DP303c in Patients With HER2-positive Advanced Breast Cancer |
HER2-positive Advanced Breast Cancer |
Not Yet Recruiting |
2023-06-13 |
| Phase 2/3 |
| NCT07165886 |
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in… |
Gastroenteropancreatic Neuroendocrine Tumors |
Recruiting |
2026-04-24 |
| NCT05761028 |
A Study of CM310 in Subjects With Moderate to Severe Asthma |
Moderate to Severe Asthma |
Recruiting |
2023-12-15 |
| NCT06547333 |
A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease |
Chronic Obstructive Pulmonary Disease |
Not Yet Recruiting |
2024-08-14 |
| Phase 2 |
| NCT07418736 |
A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive… |
Chronic Obstructive Pulmonary Disease |
Recruiting |
2026-02-18 |
| NCT06947291 |
Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound)… |
Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors |
Recruiting |
2025-09-08 |
| NCT06505395 |
A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection… |
Gastrointestinal Neuroendocrine Pancreatic Tumor |
Recruiting |
2024-08-26 |
| NCT07798193 |
A Study of SYH2085 Tablets Compared With Placebo in Chinese Adult Patients With… |
Influenza |
Not Yet Recruiting |
2026-09-01 |
| NCT07684287 |
A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive… |
Epithelioid Hemangioendothelioma |
Not Yet Recruiting |
2026-07-06 |
| NCT07116824 |
HB1801 Combined Treatment of HER2-positive Breast Cancer |
HER2-positive Breast Cancer |
Not Yet Recruiting |
2025-08-12 |
| NCT07083505 |
A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast… |
Advanced Breast Cancer |
Not Yet Recruiting |
2025-07-24 |
| NCT06957379 |
Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for… |
HR+/HER2- Advanced/Metastatic Breast Cancer |
Active, Not Recruiting |
2025-05-04 |
| NCT06525350 |
A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and… |
Locally Advanced/Recurrent or Distant Metastasized Non-small Cell Lung Cancer With MET Overexpression |
Not Yet Recruiting |
2024-07-29 |
| Phase 1/2 |
| NCT07241936 |
A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of… |
Advanced Solid Tumors |
Recruiting |
2025-11-28 |
| NCT05445154 |
SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute… |
Newly Diagnosed Acute Myeloid Leukemia (AML) |
Recruiting |
2022-07-06 |